Embla Medical hf
CSE:EMBLA

Watchlist Manager
Embla Medical hf Logo
Embla Medical hf
CSE:EMBLA
Watchlist
Price: 35.9 DKK -1.1% Market Closed
Market Cap: 15.3B DKK
Have any thoughts about
Embla Medical hf?
Write Note

Embla Medical hf
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Embla Medical hf
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Embla Medical hf
CSE:EMBLA
Income from Continuing Operations
$69.4m
CAGR 3-Years
10%
CAGR 5-Years
-4%
CAGR 10-Years
2%
O
Ossur hf
CSE:OSSR
Income from Continuing Operations
$57.1m
CAGR 3-Years
67%
CAGR 5-Years
-7%
CAGR 10-Years
2%
No Stocks Found

Embla Medical hf
Glance View

Market Cap
15.3B DKK
Industry
Health Care

Össur hf is a global orthopaedics company, which engages in the design, development, manufacture, and sale of non-invasive orthopedic products. The firm is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. The firm's business activities are divided into three business segment: The Prosthetics, its product portfolio includes a range of lower and upper limb prosthetic components; The Bracing & Supports, which offers the Unloader One range of knee braces that relieve pain from knee osteoarthritis, as well as the Unloader Hip which is designed to reduce pain by optimizing load dispersion for patients suffering from mild and moderate osteoarthritis of the hip; and The Patient Care, which operates a network of Patient Care clinics around the world, with each one catering to individual patients and their needs.

EMBLA Intrinsic Value
39.12 DKK
Undervaluation 8%
Intrinsic Value
Price

See Also

What is Embla Medical hf's Income from Continuing Operations?
Income from Continuing Operations
69.4m USD

Based on the financial report for Sep 30, 2024, Embla Medical hf's Income from Continuing Operations amounts to 69.4m USD.

What is Embla Medical hf's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
2%

Over the last year, the Income from Continuing Operations growth was 32%. The average annual Income from Continuing Operations growth rates for Embla Medical hf have been 10% over the past three years , -4% over the past five years , and 2% over the past ten years .

Back to Top